BACR 2017 Conferences The BACR hosts a number of specialist cancer meetings to bring together the latest thinking in cancer research. Having links with organisations such as EACR,NCRI and RSM boosts opportunities for networking and establishing collaborations with leaders in cancer research. Interested in attending/or presenting then visit www.bacr.org.uk/events
Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial
Roberto Pili, Glenn Liu, Sreenivasulu Chintala, Hendrick Verheul, Shabnam Rehman, Kristopher Attwood, Martin A Lodge, Richard Wahl, James I Martin, Kiersten Marie Miles, Silvia Paesante, Remi Adelaiye, Alejandro Godoy, Serina King, James Zwiebel and Michael A Carducci
Br J Cancer 2017 116: 874-883; advance online publication, February 21, 2017; 10.1038/bjc.2017.33
PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype
Onofrio Antonio Catalano, Gary Lloyd Horn, Alberto Signore, Carlo Iannace, Maria Lepore, Mark Vangel, Angelo Luongo, Marco Catalano, Constance Lehman, Marco Salvatore, Andrea Soricelli, Ciprian Catana, Umar Mahmood and Bruce Robert Rosen
Br J Cancer 2017 116: 893-902; advance online publication, February 16, 2017; 10.1038/bjc.2017.26
Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).